Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frontier Angel Fund is a regional angel investment group headquartered in Kalispell, Montana, dedicated to supporting early-stage, high-growth companies in the Pacific Northwest and Rocky Mountain regions. Established in 2006, the fund operates as a member-managed investment vehicle, pooling capital and expertise from accredited investors to provide seed and early-stage financing. While the fund is a generalist investor, it maintains a significant presence in the healthcare and life sciences sectors through its portfolio companies. The organization focuses on providing not only capital but also strategic mentorship and networking opportunities to help entrepreneurs scale their businesses. Frontier Angel Fund has successfully launched multiple fund iterations, including Frontier Angel Fund 2 and Frontier Angel Fund 3, to continue its mission of fostering regional innovation. It is recognized as one of the most active angel groups in the inland Northwest, often collaborating with other regional funds for syndicated deals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frontier Angel Fund.